Zongertinib in HER2-altered breast cancer: Preclinical activity and preliminary results from a phase Ia dose-escalation study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

A high-throughput workflow integrates DNA methylation and RNA sequencing in single cells, enabling more complete insights ...

Spatial transcriptomics and lethality-associated stromal remodeling of colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...